Dir LEITNER Acquires 101,772 Of HYPERTENSION DIAGNOSTICS INC HDII
Dow Jones & Company, Inc. - Sep 08 at 11:15
Company Symbols: NASDAQ-OTCBB:HDII
SOURCE: Form 4
ISSUER: HYPERTENSION DIAGNOSTICS INC
SYMBOL: HDII
FILER: LEITNER LARRY
TITLE: Director
DATE TRANSACTION SHARES PRICE VALUE
9/2/10 Exercise* 101,772 $0.14 $14,248
OWNERSHIP: 1,419,265 (Direct)
* - Exercised 1 year before expiration.
The Form 4 is filed with the Securities and Exchange Commission by insiders
to report transactions in their companies' shares. Open market purchases
and sales must be reported within two business days of the transaction.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM